公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2005 | Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area | Huang Y.-H.; Wu J.-C.; CHIEN-HUNG CHEN ; Chang T.-T.; Lee P.-C.; Chau G.-Y.; Lui W.-Y.; Chang F.-Y.; Lee S.-D. | Liver International | 66 | 64 | |
2007 | Involvement of NO/cGMP signaling in the apoptotic and anti-angiogenic effects of β-lapachone on endothelial cells in vitro | HSIU-NI KUNG ; CHUNG-LIANG CHIEN ; Chau G.-Y.; Don M.-J.; KUO-SHYAN LU ; Chau Y.-P. | Journal of Cellular Physiology | 30 | 25 | |
2012 | Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection | Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE ; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; PEI-JER CHEN | Annals of Surgery | 111 | 106 | |
2018 | Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan | Wang, CK; MING-CHIH HO ; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN ; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; PO-HUANG LEE ; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Lin S.-M.; GUAN-TARN HUANG ; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; PO-CHIN LIANG ; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; ANN-LII CHENG ; CHIUN HSU ; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; CHIA-HSIEN CHENG ; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; YEN-HSUAN NI ; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Surveillance group; Diagnosis group; Staging group; Surgery group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group | Journal of the Formosan Medical Association = Taiwan yi zhi | 90 | 87 | |
2006 | Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: A multicenter, randomized, double-blind, placebo-controlled trial | Shao Y.-F.; Yang J.-M.; Chau G.-Y.; Sirivatanauksorn Y.; Zhong S.-X.; Erhardtsen E.; Nivatvongs S.; PO-HUANG LEE | American Journal of Surgery | 78 | 67 | |
2016 | Surgery for intermediate and advanced hepatocellular carcinoma: A consensus report from the 5th Asia-pacific primary liver cancer expert meeting (apple 2014) | MING-CHIH HO ; Hasegawa K.; Chen X.-P.; Nagano H.; Lee Y.-J.; Chau G.-Y.; Zhou J.; Wang C.-C.; Choi Y.R.; Poon R.T.-P.; Kokudo N. | Liver Cancer | 69 | 69 | |
2005 | Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells | Yang L.-J.; Jeng C.-J.; HSIU-NI KUNG ; Chang C.-C.; Wang A.-G.; Chau G.-Y.; Don M.-J.; Chau Y.-P. | Journal of Biomedical Science | 48 | 43 | |